Log in

American Vanguard (NYSE:AVD) Upgraded at Zacks Investment Research

Posted on Tuesday, June 30th, 2020 by MarketBeat

American Vanguard (NYSE:AVD) was upgraded by Zacks Investment Research from a "sell" rating to a "hold" rating in a research note issued to investors on Tuesday, Zacks.com reports.

According to Zacks, "American Vanguard Corporation is a diversified specialty and agricultural products company focusing on crop protection, turf and ornamental markets, and public health applications. The Company has continued its successful strategy of acquiring or licensing both new and well-established product lines that serve numerous high valued market niches. New product development and international expansion also provide an additional stimulus for growth. Through skilful marketing, diligent product registration, quality manufacturing, American Vanguard has positioned itself to capitalize on developing trends in modern agriculture. American Vanguard continues to meet the needs of a world demanding ever-increasing quantities of agricultural products for human food, animal feed, natural fibers and alternative fuels. "

Separately, ValuEngine lowered shares of American Vanguard from a "buy" rating to a "hold" rating in a research note on Thursday, April 2nd.

Shares of NYSE:AVD traded up $0.13 on Tuesday, hitting $13.76. The company's stock had a trading volume of 114,634 shares, compared to its average volume of 134,239. American Vanguard has a 12 month low of $11.35 and a 12 month high of $19.60. The company has a market capitalization of $395.39 million, a price-to-earnings ratio of 38.22 and a beta of 1.01. The stock's 50-day moving average is $12.89 and its two-hundred day moving average is $15.49. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.25 and a current ratio of 2.52.

American Vanguard (NYSE:AVD) last posted its quarterly earnings data on Monday, May 11th. The basic materials company reported $0.02 earnings per share for the quarter, topping the consensus estimate of $0.01 by $0.01. The business had revenue of $95.96 million during the quarter, compared to the consensus estimate of $96.05 million. American Vanguard had a net margin of 2.20% and a return on equity of 3.03%. Equities analysts expect that American Vanguard will post 0.48 earnings per share for the current fiscal year.

In other news, Director Esmail Zirakparvar bought 3,280 shares of the firm's stock in a transaction that occurred on Friday, June 12th. The stock was acquired at an average price of $12.49 per share, with a total value of $40,967.20. Following the completion of the purchase, the director now directly owns 41,939 shares of the company's stock, valued at approximately $523,818.11. The acquisition was disclosed in a filing with the SEC, which is available at this link. 5.30% of the stock is currently owned by company insiders.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in AVD. ArrowMark Colorado Holdings LLC acquired a new stake in American Vanguard in the fourth quarter valued at $3,135,000. Janus Henderson Group PLC increased its holdings in American Vanguard by 56.7% during the first quarter. Janus Henderson Group PLC now owns 1,241,483 shares of the basic materials company's stock valued at $17,952,000 after buying an additional 449,343 shares during the last quarter. State Street Corp raised its holdings in American Vanguard by 7.5% in the 1st quarter. State Street Corp now owns 874,391 shares of the basic materials company's stock worth $12,661,000 after purchasing an additional 61,224 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS bought a new position in shares of American Vanguard in the first quarter worth about $193,000. Finally, Charles Schwab Investment Management Inc. raised its stake in American Vanguard by 2.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 166,841 shares of the basic materials company's stock worth $3,249,000 after acquiring an additional 3,852 shares during the period. Institutional investors and hedge funds own 79.55% of the company's stock.

American Vanguard Company Profile

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. The company manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.

Featured Story: Channel Trading

Get a free copy of the Zacks research report on American Vanguard (AVD)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Top Ten Brokerages You Can Trust

There are more than 500 brokerages and research houses that hire analysts to issue ratings and recommendations. Collectively, these brokerages and their analysts publish approximately 175,000 ratings each year. Every trading day, there are nearly 700 reports and recommendations that are released to the public. To say that it's difficult to separate the signal from the noise when interpreting this data would be an understatement.

MarketBeat has developed a system to track each brokerage and research house's stock recommendations and score them based on their past performance. If Goldman Sachs predicted that Apple's stock price was going to hit $150.00 on a specific date, how accurate were they? If Bank of America issued a "strong buy" rating on a stock, how did that stock perform compared to the broader market over the following twelve months. This tracking system has been applied to the 650,000+ ratings that MarketBeat has tracked during the last five years to identify which brokerages you can really trust (and which you can safely ignore).

This slide show lists the 10 brokerages who have issued the most accurate analyst recommendations over the past several years, as measured by the performance of their "buy" ratings and the accuracy of their price targets.

View the "Top Ten Brokerages You Can Trust".

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.